[1]
M. Zuo, “Comparison of Efficacy and Safety of Imatinib and Dasatinib in the Treatment of Chronic-phase Chronic Myeloid Leukemia”, HSET, vol. 74, pp. 1807–1816, Dec. 2023, doi: 10.54097/yf8hhr56.